Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
IMMUCELL CORP /DE/ market cap for the quarter ending 2026-07-31 was $100.54M, a 79.27% increase year-over-year.
IMMUCELL CORP /DE/ market cap for the quarter ending 2026-06-30 was $91.41M, a 45.19% increase year-over-year.
IMMUCELL CORP /DE/ market cap for the quarter ending 2026-05-01 was $78.84M, a 72.07% increase year-over-year.
IMMUCELL CORP /DE/ market cap for the quarter ending 2026-03-31 was $57.27M, a 33.09% increase year-over-year.
IMMUCELL CORP /DE/ market cap for fiscal 2026 was $100.54M.
IMMUCELL CORP /DE/ market cap for fiscal 2025 was $55.63M, a 20.31% increase from fiscal 2024.
IMMUCELL CORP /DE/ market cap for fiscal 2024 was $46.24M, a 17.21% increase from fiscal 2023.
IMMUCELL CORP /DE/ market cap for fiscal 2023 was $39.45M, a 16.51% decline from fiscal 2022.